Literature DB >> 24236869

An alternative approach to estimate age-related mortality of kidney transplant recipients compared to the general population: results in favor of old-to-old transplantations.

Yohann Foucher1, Ahmed Akl, Vanessa Rousseau, Katy Trébern-Launay, Marine Lorent, Michèle Kessler, Marc Ladrière, Christophe Legendre, Henri Kreis, Lionel Rostaing, Nassim Kamar, Georges Mourad, Valérie Garrigue, Emmanuel Morelon, Fanny Buron, Jean-Pierre Daurès, Jean-Paul Soulillou, Magali Giral.   

Abstract

Compared to dialysis, kidney transplantation appears to be the best treatment for chronic kidney failure, even for older aged patients. Nevertheless, the individual benefit of transplanting elderly patients has to be balanced against the corresponding increase in the number of patients awaiting grafts. We analyzed the excess mortality related to kidney transplant recipients by taking into account the expected mortality of the general population (additive regression model for relative survival). We applied this method to a cohort of patients who received a first deceased-donor kidney transplant between 1998 and 2009 in France (DIVAT, n = 3641). Overall 10-year mortality was 13%. As expected, recipient age was the main risk factor associated with overall mortality. In contrast, recipient age was no longer significantly associated with the excess of mortality related to kidney transplant status by subtracting the expected mortality of the general population. Delayed graft function (DGF), pretransplantation immunization, and past history of diabetes appeared as the main risk factors of this higher mortality rate. Our results constitute a strong argument in favor of kidney transplantation, regardless of the patient's age. Preventing DGF may be more effective for decreasing the risk of death specifically attributable to the disease.
© 2013 Steunstichting ESOT. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  aging; clinical epidemiology; kidney transplantation; mortality; relative survival

Mesh:

Year:  2013        PMID: 24236869     DOI: 10.1111/tri.12241

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  5 in total

1.  Long-term mortality among kidney transplant recipients with and without diabetes: a nationwide cohort study in the USA.

Authors:  Jessica L Harding; Meda Pavkov; Zhensheng Wang; Stephen Benoit; Nilka Ríos Burrows; Giuseppina Imperatore; Ann L Albright; Rachel Patzer
Journal:  BMJ Open Diabetes Res Care       Date:  2021-05

2.  Mortality Prediction after the First Year of Kidney Transplantation: An Observational Study on Two European Cohorts.

Authors:  Marine Lorent; Magali Giral; Manuel Pascual; Michael T Koller; Jürg Steiger; Katy Trébern-Launay; Christophe Legendre; Henri Kreis; Georges Mourad; Valérie Garrigue; Lionel Rostaing; Nassim Kamar; Michèle Kessler; Marc Ladrière; Emmanuel Morelon; Fanny Buron; Dela Golshayan; Yohann Foucher
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

3.  Impact of acute kidney injury in expanded criteria deceased donors on post-transplant clinical outcomes: multicenter cohort study.

Authors:  Woo Yeong Park; Min-Seok Choi; Young Soo Kim; Bum Soon Choi; Cheol Whee Park; Chul Woo Yang; Yong-Soo Kim; Kyubok Jin; Seungyeup Han; Byung Ha Chung
Journal:  BMC Nephrol       Date:  2019-02-04       Impact factor: 2.388

4.  Impact of acute kidney injury in deceased donors with high Kidney Donor Profile Index on posttransplant clinical outcomes: a multicenter cohort study.

Authors:  Woo Yeong Park; Yoon Kyung Chang; Young Soo Kim; Kyubok Jin; Chul Woo Yang; Seungyeup Han; Byung Ha Chung
Journal:  Kidney Res Clin Pract       Date:  2021-03-05

5.  Age at Time of Kidney Transplantation as a Predictor for Mortality, Graft Loss and Self-Rated Health Status: Results From the Swiss Transplant Cohort Study.

Authors:  Nadine Beerli; Kris Denhaerynck; Isabelle Binet; Suzan Dahdal; Michael Dickenmann; Delaviz Golshayan; Karine Hadaya; Uyen Huynh-Do; Aurelia Schnyder; Sabina M De Geest; Oliver Mauthner
Journal:  Transpl Int       Date:  2022-01-27       Impact factor: 3.782

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.